SCHEMBL8305416

SCHEMBL8305416

CC(=NOCCOc1ccc(CC2SC(=O)NC2=O)cc1)c1ccc(O)nc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 15/20 0.76
CYP3A4 P08684 2/20 0.51
RXRA P19793 1/20 0.51
MEN1 O00255 1/20 0.49
ALDH1A1 P00352 1/20 0.49
TP53 P04637 1/20 0.49
CYP1A2 P05177 1/20 0.49
MAPT P10636 1/20 0.49
HPGD P15428 1/20 0.49
ALOX15 P16050 1/20 0.49
TSHR P16473 1/20 0.49
KMT2A Q03164 1/20 0.49
HSD17B10 Q99714 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
FFAR1 O14842 4/20 0.48
MPC2 O95563 2/20 0.48
CYP2C8 P10632 2/20 0.48
CYP2C9 P11712 2/20 0.48
PPARA Q07869 1/20 0.47
HRH3 Q9Y5N1 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8305406 1.00 PPARG (0.76) PPARGCYP3A4RXRAMEN1ALDH1A1
SCHEMBL6898686 0.89 PPARG (0.73) PPARGCYP3A4RXRAMEN1ALDH1A1
SCHEMBL6898681 0.89 PPARG (0.73) PPARGCYP3A4RXRAMEN1ALDH1A1
SCHEMBL8309044 0.88 PPARG (0.69) PPARGCYP3A4RXRAMEN1ALDH1A1
SCHEMBL8309046 0.88 PPARG (0.69) PPARGCYP3A4RXRAMEN1ALDH1A1
SCHEMBL6904420 0.88 PPARG (0.72) PPARGCYP3A4RXRAMEN1ALDH1A1
SCHEMBL6904419 0.88 PPARG (0.72) PPARGCYP3A4RXRAMEN1ALDH1A1
SCHEMBL6898697 0.86 PPARG (1.00) PPARGCYP3A4RXRAMEN1ALDH1A1
SCHEMBL6898699 0.86 PPARG (1.00) PPARGCYP3A4RXRAMEN1ALDH1A1
SCHEMBL6902220 0.86 PPARG (0.70) PPARGCYP3A4RXRAMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5972959-A Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY, LIMITED (JP) 1999-10-26 US disclosed
EP-0708098-B1 Oxime derivatives, their preparation and their therapeutic use SANKYO CO (JP) 1999-03-03 EP disclosed
EP-0708098-A1 Oxime derivatives, their preparation and their therapeutic use SANKYO COMPANY LIMITED (JP) 1996-04-24 EP disclosed